Please login to the form below

Not currently logged in
Email:
Password:

UK's ABPI rejects GMC off-label suggestions

The ABPI has responded to the GMC's consultation on prescribing off-label drugs

Prescribing off-label drugs when a licensed alternative exists increases risks to patients and threatens the development of new medicines, the Association of the British Pharmaceutical Industry (ABPI) has said in response to the General Medical Council's (GMC) consultation on the matter.

The GMC is proposing to allow doctors to prescribe drugs off-label when there is a licensed alternative, as this "does not interfere with their [doctors'] ethical considerations," in an attempt to make off-label use clearer to its members.

However, the ABPI said that even if doctors believe it is the right thing to do, off-label prescribing will continue to put patients at risk, because of a lack of safety data for non-approved uses for drugs.

It said: "ABPI recommends that the GMC maintains unchanged its existing guidance (2008) on the use of off-label and unlicensed medicines, which emphasises that while doctors should make 'good use of the resources available' this does not extend to prescribing a medicine outside the terms of its licence, unless the doctor is satisfied that it would better serve the patient's needs than a licensed alternative.

"The existing guidance does not imply that cost can be an acceptable consideration in choosing an unlicensed medicine when there is a licensed alternative that meets the same clinical need."

6th June 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health...

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...